Visit Lucid news for the latest in psychedelics
Psychedelic U offers a starting point for those new to psychedelics and for experienced psychonauts alike. We publish clear, fact checked articles reviewed by top experts, as well as Lucid News editors. The articles include links to recommended resources for more detailed, vetted information. This site is now in public beta. It’s a living document, responsive to your feedback. Please send suggestions and corrections. New content modules are coming soon. Sign up for our newsletter to receive announcements and opportunities to be a part of this effort to make reliable information about psychedelics widely available.
More people than ever are curious about psychedelics, the substances – plants, fungi and compounds – that create expanded states of consciousness. New research shows these substances could be promising medicines, particularly in conjunction with therapy. A central element of Indigenous spiritual practices since ancient times, psychoactive substances are now being embraced by other cultures to support personal growth, creativity and a deeper connection to the divine.
Ketamine, unlike the classic psychedelic substances, is a legal dissociative anesthetic that is used…
There are myriad ways to experience psychedelics, from clinical therapy to ceremony to recreationally…
Research suggests psilocybin may have potential as a treatment for OCD. Psilocybin interacts with…

While psychedelics have a history of sparking creativity, the first modern study to investigate the potential of psilocybin to enhance the brain’s ability to unlock creativity and problem solving is underway at the University of Texas, Austin and groups like Center for MINDS is exploring this connection.
Recent research surveying 1,435 microdosers suggests that microdosing’s duration of effect might be more like that of drinking a coffee, with benefits that come and go by day’s end.
A new report from the RAND Corporation shows that nearly one-quarter of U.S. adults now support the legal use of psilocybin with public support driven by approval for therapeutic not personal access or recreational use.